Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 10, 2012

Voters Split on Expanding a Biodefense Program Beyond the Former USSR

  • A recent GEN poll suggests an even split on whether Washington is wise in growing a biodefense program beyond the countries of the former Soviet Union. Equal percentages (42.9%) of respondents support and oppose the move, with 14.3% undecided.

    The Cooperative Biological Engagement Program (CBEP) saw its budget grow 53% year-over-year to $259.5 million under the National Defense Authorization Act (NDAA), enacted by President Barack Obama on New Year’s Eve. The extra spending will allow CBEP to expand into Iraq, India, Djibouti, South Africa, and Tanzania. Additionally, CBEP is engaged with officials in Pakistan, Afghanistan, Kenya, and Uganda. That expansion worried the House of Representatives enough to persuade the Senate to allow CBEP only 80% of its funding pending more details on the expansion.

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »